Streamr / HarryPotterTrumpSonic100Inu
0.00000015
02-March-25 17:36:29
realtime
Instruments
-8.75E-08
-36.58%
Today's range
0.00000015 - 0.00000015
ISIN
FXDATABTC
Source
HITB
-
Clover Health Investments (NASDAQ:CLOV) Price Target Raised to $4.50
03 Mar 2025 09:02:15 By Buzz FX
-
Fireweed Metals Corp. (CVE:FWZ) Director Buys C$225,000.00 in Stock
03 Mar 2025 09:02:15 By Buzz FX
-
OPKO Health (NASDAQ:OPK) Receives Buy Rating from HC Wainwright
03 Mar 2025 09:02:15 By Buzz FX
-
Middlesex Water (NASDAQ:MSEX) Rating Increased to Outperform at Robert W. Baird
03 Mar 2025 09:02:15 By Buzz FX
-
Axsome Therapeutics (NASDAQ:AXSM) Price Target Raised to $160.00
03 Mar 2025 09:02:15 By Buzz FX
-
Iovance Biotherapeutics (NASDAQ:IOVA) Price Target Lowered to $30.00 at Chardan Capital
03 Mar 2025 09:02:15 By Buzz FX
-
Immunovant (NASDAQ:IMVT) Now Covered by Analysts at Jefferies Financial Group
03 Mar 2025 09:02:15 By Buzz FX
-
Karyopharm Therapeutics (NASDAQ:KPTI) Given New $54.00 Price Target at Robert W. Baird
03 Mar 2025 09:02:15 By Buzz FX
-
03 Mar 2025 09:02:15 By Buzz FX
-
Barclays Has Lowered Expectations for Definitive Healthcare (NASDAQ:DH) Stock Price
03 Mar 2025 09:02:15 By Buzz FX
-
Nuvalent (NASDAQ:NUVL) Given Buy Rating at HC Wainwright
03 Mar 2025 09:02:15 By Buzz FX
-
HC Wainwright Issues Pessimistic Forecast for CareDx (NASDAQ:CDNA) Stock Price
03 Mar 2025 09:02:15 By Buzz FX
-
Robert W. Baird Issues Pessimistic Forecast for Astrana Health (NASDAQ:ASTH) Stock Price
03 Mar 2025 09:02:15 By Buzz FX
-
Beigene (NASDAQ:ONC) Stock Rating Upgraded by Bank of America
03 Mar 2025 09:02:15 By Buzz FX
-
Landsea Homes (NASDAQ:LSEA) Given New $7.00 Price Target at Barclays
03 Mar 2025 09:02:15 By Buzz FX
-
MongoDB (NASDAQ:MDB) Upgraded to "Neutral" at Monness Crespi & Hardt
03 Mar 2025 09:02:15 By Buzz FX
-
HC Wainwright Reiterates "Buy" Rating for ANI Pharmaceuticals (NASDAQ:ANIP)
03 Mar 2025 09:02:15 By Buzz FX
-
Alumis' (ALMS) Buy Rating Reiterated at HC Wainwright
03 Mar 2025 09:02:15 By Buzz FX
-
03 Mar 2025 09:02:15 By Buzz FX
-
Akero Therapeutics (NASDAQ:AKRO) Given New $75.00 Price Target at HC Wainwright
03 Mar 2025 09:02:15 By Buzz FX